BioSpace News Archive

According to the report, the global neuropathic pain therapeutics market was valued at US$ 5.8 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

Radiosurgery treatment uses focused beams of special ionized radiations directed at the patient. It is primarily used to treat tumors.

MET409 demonstrated notable improvements in decreased liver fat content and differentiated impacts on pruritus and LDL cholesterol after 12 weeks of treatment in NASH patients

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, has been invited to present a Company overview during the following September investor conferences. Details are as follows: Event LD Micro Virtual Conference Date September 2, 2020 Time 11:20 p.m. ET Event Wall Street Investment Forum Date September 10, 2020

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that Walter Klemp , Chairman and Chief Executive Officer, will present at the LD Micro 500 Virtual Investor Conference being held virtu

CTT Pharmaceutical Holdings, Inc., (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, today announced that its wholly owned Canadian subsidiary, CTT Pharma Inc. (the “Company” or “CTT”), has filed a statement of claim with the Ontario Superior Court of Justice aga

Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the United States Patent Office (USPTO) issued U.S. Patent No. 10,751,413 providing product protection for SRK-015, including composition of matter and methods of use, with an expiry of January 2037. “We are at the forefro

NeuPath Health Inc. (TSXV:NPTH) (formerly Klinik Health Ventures Corp.) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, today announced its financial and operating results for the three and six months ended June 30, 2020. For further details on the results, please refer to NeuPath

Apricorn, the leading manufacturer of software-free, 256-bit AES XTS hardware-encrypted USB data storage devices, today announced that FIPS 140-2 level 3 validation (certification #3703) has been awarded to the Aegis Secure Key 3NX by the National Institute of Standards and Technology

Lantern Pharma (NASDAQ: LTRN) , a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug discovery and development, and identify patients who will benefit from its targeted oncology drug candidates, announced today that Panna Sh